Alvotech (ALVO) P/E Ratio History
Historical price-to-earnings valuation from 2025 to 2025
Loading P/E history...
ALVO Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 8, 2026, Alvotech (ALVO) trades at a price-to-earnings ratio of 32.0x, with a stock price of $3.20 and trailing twelve-month earnings per share of $0.10.
The current P/E is 94% below its 5-year average of 522.1x. Over the past five years, ALVO's P/E has ranged from a low of 28.5x to a high of 1973.1x, placing the current valuation at the 25th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.3x, ALVO trades at a 43% premium to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 177.5x.
Relative to the broader market, ALVO commands a significant premium over the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our ALVO DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
ALVO P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $178B | 23.1 | 7.86 | +88% | |
| $42B | 30.0 | - | +183%Best | |
| $358B | 85.5 | - | -1% | |
| $536B | 38.4 | - | -58% | |
| $151B | 19.5 | - | -4% | |
| $28B | 21.7 | - | -21% | |
| $74B | 17.1 | 2.70 | +8% | |
| $277B | 15.4Lowest | 0.73Best | +8% | |
| $92B | 29.2 | 0.75 | +15% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
ALVO Historical P/E Data (2025–2025)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2025 Q4 | Wed Dec 31 2025 00:00:00 GM | $5.13 | $0.00 | 1973.1x | +278% |
| FY2025 Q3 | $8.19 | $0.21 | 38.5x | -93% | |
| FY2025 Q2 | Mon Jun 30 2025 00:00:00 GM | $9.12 | $0.19 | 48.2x | -91% |
| FY2025 Q1 | Mon Mar 31 2025 00:00:00 GM | $9.67 | $0.34 | 28.5x | -95% |
Average P/E for displayed period: 522.1x
See ALVO's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ALVO Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ALVO vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonALVO — Frequently Asked Questions
Quick answers to the most common questions about buying ALVO stock.
Is ALVO stock overvalued or undervalued?
ALVO trades at 32.0x P/E, below its 5-year average of 522.1x. At the 25th percentile of historical range, the stock is priced at a discount to its own history.
How does ALVO's valuation compare to peers?
Alvotech P/E of 32.0x compares to sector median of 22.3x. The premium reflects expected growth above peers.
What is ALVO's PEG ratio?
ALVO PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2025-2025.